Brief: Omnicell Q4 Revenue USD 307 Million Vs. IBES Estimate USD 299.6 Million
06/02/2025 11:30
Feb 06 (Reuters) - Omnicell Q4 adjusted EBITDA USD 46 million vs. IBES estimate USD 42.7 million. * Q4 net income USD 16 million * Q4 adjusted net income USD 28 million vs. IBES estimate USD 26.9 million
Recent news on Omnicell
See all newsBrief: Omnicell Welcomes Hospital Pharmacy Leader Rick Couldry As Senior Vice President
Omnicell Q1 adjusted EPS beats helped by connected devices demand, raises FY outlook
U.S. RESEARCH ROUNDUP-Amazon, Estée Lauder, Ralph Lauren
Omnicell Q4 EPS misses estimates
Omnicell Q3 adjusted EPS beats estimates, driven by connected devices and services